MedTrace Logo

Modulation of Molecular Fingerprinting in Pediatric Sepsis

NCT02055105 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-11-12

No results posted yet for this study

Summary

The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.

Conditions

  • Systemic Inflammatory Response Syndrome

Interventions

PROCEDURE

miRNA in Sepsis

miRNA in Sepsis

Sponsors & Collaborators

  • Phoenix Children's Hospital

    lead OTHER

Principal Investigators

  • Frederick A Willyerd, MD · Phoenix Children's Hospital

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2027-06-30
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02055105 on ClinicalTrials.gov